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in the treatment of primary rhegmatogenous 
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Abstract 
Background: The basis of retinal detachment repair is sealing the retinal breaks. In order to seal the retinal breaks, 
chorioretinal adhesion around these lesions has to be achieved. Laser retinopexy is not immediate thus necessitates 
the use of a temporal endotamponade to maintain both tissues in apposition. We propose the use of a patch of lyo-
philized human amniotic membrane (LAMPatch) in order to occlude the retinal tear effectively until the chorioretinal 
adhesion is settled, overcoming the risks and limitations of the current tamponades.
Methods: 23-gauge vitrectomy was performed on eyes with primary retinal detachment with single retinal breaks 
of less than one-hour extension. A LAMPatch was deployed over the retinal breaks after retina was repositioned with 
perfluorocarbon. Neither gas nor silicon oil were injected.
Results: Six eyes of six patients with total or partial retinal detachment were included. Retinas remained reattached 
in all cases until the end on follow-up (3, 5 months). Best-corrected visual acuity at 1-week postop was between 20/30 
and 20/100. Neither elevations of intraocular pressure, cataracts nor signs of inflammation were registered during 
follow-up. No second surgeries were needed.
Conclusion: This technique has proven to be safe and effective in this small case series. No intraocular pressure rise, 
inflammation or cataracts were registered until last follow-up visit.
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Background
The basis of retinal detachment (RD) repair was estab-
lished by Jules Gonin 100  years ago and it is still up to 
date: sealing the retinal break [1]. Vitrectomy has become 
the prevalent surgical technique, with a reattachment 
success rate of approximately 85–95%, regardless of the 
final visual acuity or side effects [2].
In order to seal the retinal breaks, chorioretinal adhe-
sion around these lesions has to be achieved. Laser retin-
opexy is the preferred technique, nevertheless its effect 
is not immediate [3], thus necessitates the use of a tem-
poral endotamponade to maintain both tissues in appo-
sition. Long-acting gases and silicone oil are widely used 
to accomplish this purpose; nonetheless, they are not 
exempt from side effects, namely, visual acuity impair-
ment during tamponade, cataracts [4] and glaucoma [5] 
among others. Furthermore, due to their physical proper-
ties, they are prone to fail in the context of inferior retinal 
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breaks, and hence, require prolonged anti-natural head 
positions, which are difficult to achieve by patients.
Human amniotic membrane (HAM) has been reported 
to be safe for intraocular use; moreover, as Rizzo et  al. 
described, it appears to promote retinal healing [6–8]. 
Lyophilization of HAM maintains its histological struc-
ture [9] and, at the same time, confers beneficial features 
regarding its storage, biosafety and surgical handling.
We propose the use of a patch of lyophilized HAM 
(LAMPatch) over the retinal tear as a localized tempo-
rary tamponading agent in replacement of currently used 
tamponades, in order to occlude the retinal tear effec-
tively until the chorioretinal adhesion is settled, overcom-
ing the risks and limitations of the current tamponades.
Materials and methods
This is a consecutive, single-center case series of six eyes 
of six patients with primary RD treated by a single sur-
geon with pars plana 23-gauge vitrectomy with the Con-
stellation System (Alcon Laboratories, Inc., Fort Worth, 
TX, USA). Inclusion criteria were: eyes with primary RD, 
single retinal breaks of less than one hour extension and 
minimal to no signs of vitreoretinal proliferation. Patients 
with previous retinal surgeries were excluded. Three 
cases had superior breaks, and three cases had infe-
rior breaks. Surgical repair took place between Novem-
ber 2019 and June 2020. Written informed consent for 
participation was obtained from all patients. The study 
was in compliance with the Declaration of Helsinki. An 
independent ethical committee approved this study in 
accordance with the Helsinki declaration.
Preoperatively, an ophthalmic history and a complete 
ophthalmic examination including refraction with assess-
ment of best-corrected visual acuity (BCVA) Goldmann 
applanation tonometry and a fundus dilated ophthalmic 
examination was performed.
HAM lyophilization process
HAMs were obtained from Amnios, Inc, (Buenos Aires, 
Argentina) where HAM is harvested from human pla-
centas following standardized procedures. A sample of 
HAM is previously collected to perform Protein Chain 
Reaction (PCR) for HIV, Hepatitis B, Hepatitis C, Brucel-
losis, Toxoplasmosis, CMV, Syphilis and Chagas before 
dispensation. Once the procedure of cleansing and dis-
secting of the HAM is finished, fragments of different 
sizes are loaded into sterile Petri dishes, wich are placed 
in a freezer at −80 ℃ for 2 h. Then, the freezed plates are 
stored in the freeze-dryer shelves under a determined 
vacuum (less than 15 Pascals). The final products are 
exposed to gamma radiation (15–20kgray) for sterili-
zation. (Process validated by the Argentinian National 
Atomic Energy Commission).
Surgical procedure
M.S. performed all surgical procedures with the Alcon 
Constellation system (Alcon Laboratories, Inc, Fort 
Worth, TX) as follows: A retrobulbar block was per-
formed followed by placement of three 23-gauge tro-
cars. A complete vitrectomy including a meticulous 
peripheral vitreous shave was performed. Retina was 
repositioned with either liquid perfluorocarbon or air 
ensuring that the borders of the lesions were completely 
attached and no subretinal fluid was left. Laser pho-
tocoagulation was applied around the retinal breaks. 
Perflurocarbon–liquid–air exchange was performed. 
Once the eye was full of air, tailored pieces of lyophi-
lized HAM between 3 to 6  mm in diameter (Fig.  1) 
were introduced using a 25-gauge forceps through a 
23-gauge valved trocar (mismatched caliber was inten-
tional for better tissue handling) and deployed over the 
retinal breaks. As a result of this procedure, a LAM-
Patch was firmly placed against the retina, covering the 
break. (Fig. 2) Neither gas nor silicon oil were injected. 
The trocars were then removed, and the sclerotomies 
were sutured if needed. Subconjunctival injection of 
cefazolin was administered.
Postoperative follow‑up
Immediately after surgery, no head-positioning instruc-
tions were recommended. Patients were placed on 
prednisolone acetate 1% and moxifloxacin 0.5% four 
times daily. All patients were examined postoperatively 
at the first postoperative day and then at 1-week; the 
following visits were scheduled on a monthly basis. 
Mean follow-up was 3.5  months (2–7  months). The 
postoperative evaluations included measurement of the 
BCVA and intraocular pressure (IOP), biomicroscopy 
and dilated fundus examination.
Fig. 1 LAMPatch trimming under optical microscope before been 
introduced inside the eye
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Results
Six eyes of six patients with total or partial RD were 
included (Table 1).
Retinas remained reattached in all cases from 1-day to 
the end of follow-up. All LAMPatches stayed completely 
adhered to the retinal surface covering the break at the 
1-week postoperative visit. In one case the LAMPatch 
was not in place in the vitreous cavity after a compre-
hensive fundoscopy. Patient did no referred symptoms 
at the 1-month postoperative visit (Patient 2). Neither 
was found in the vitreous cavity after a comprehen-
sive fundoscopy. Patient did not refer any symptoms. In 
another case (Patient 6) the LAMPatch was found par-
tially detached from its borders at the 5-month postop-
erative visit (Fig. 3). The other patches remained attached 
until the end of follow-up. RD did not occur at any time. 
BCVA at 1-week postop was between 20/30 and 20/100. 
Neither elevation of IOP, cataracts nor signs of inflamma-
tion were registered during follow-up. No second surger-
ies were needed.
Discussion
Vitrectomy has become the preferred surgical technique 
for addressing RD. Technological advances regarding vit-
rectomy and visualization systems have improved over-
whelmingly in the last decades, allowing the procedure to 
be faster, safer and more comfortable for patients. Not-
withstanding, vitrectomy for RD repair still has unwanted 
side effects due to the use of tamponades. Intraocular sil-
icon oil and/or expansive gases may produce, even when 
they are no longer inside the eye, visual impairment, cat-
aracts and glaucoma [4, 5]. As the efficacy of the current 
RD surgery technique (measured by the binary endpoint 
of “attached/not attached”) is well past 90%, retinal sur-
geons undertake the described side effects as part of the 
technique.
Fig. 2 LAMPatch (Black arrow) adhered to the retinal surface 
covering the retinal break
Table 1 Patient demographics
This table includes patient demographics, measurements of visual acuity and intraocular pressure and characteristics of retinal detachments
* POW1 Postoperative Week 1
** POM1 Postoperative Month 1
Patient Age Sex Type of RD Tear location Observations POW1* BCVA POM1** IOP
1 59 M Total, macula-off Superior None 20/80 18
2 47 F Partial, macula-off Superior High myope 20/60 14
3 51 F Partial, macula-on Inferior None 20/30 12
4 60 F Partial, macula-off Inferior None 20/50 12
5 67 M Total, macula-off Superior None 20/100 14
6 52 F Partial, macula-off Inferior None 20/40 14
Fig. 3 Wide-field retinography of patient 6 (see Table 1) at 5-months. 
A Black arrow shows LAMPatch in place, partially detached from its 
borders
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We believe that there is room for a different strategy 
to achieve the same results: to occlude the break and 
keep retina in position until retinopexy is consolidated, 
without the side effects caused by current endotampon-
ades. Other papers have been published adressing this 
issue using a fibrin glue plug, reporting similar benefits 
[10, 11]. We believe that lyophilized HAM could have 
additional advantages compared to fibrin glue, given its 
proven antifibrotic activity [12], a potential protective 
effect against proliferative vitreoretinopathy, not yet 
demonstrated.
We propose the use of a thin layer of lyophilized 
amniotic membrane as a patch (LAMPatch) to tem-
porary block the retinal breaks until a firm laser retin-
opexy is achieved, avoiding the use of endotamponades 
like gas or silicon oil. It is critical to understand that 
this technique does not replace laser retinopexy, con-
versely, it buys time until strong retinopexy is attained, 
generally 24 hs postop [3].
HAM has already been used in retinal surgery with 
good tolerance [8]; nevertheless, as a vital membrane, 
it has some disadvantages. Firstly, it has to be handled 
under strict cold chain compliance, resulting in limited 
viability. Secondly, since fresh HAM contains viable 
cells, they may also be a way to spread disease vec-
tors. However, after being lyophilized and sterilized by 
gamma radiation, HAM has no special storage require-
ments regarding temperature and humidity, negligible 
risk of biohazard and an enhanced durability.
Conclusion
In the present series of six cases, LAMPatch technique 
showed efficacy both in superior and inferior breaks. 
This technique has proven to be safe and effective in 
this small case series. An advantage of avoiding the use 
of endotamponades like gas or silicon oil was that the 
visual axis was not impaired and visual recovery started 
earlier. No IOP rise, inflammation or cataracts were 
registered until last follow-up visit. The limitations of 
this case series were the short follow-up and the small 
number of cases.
We propose to consider the use of the LAMPatch 
technique as an alternative approach for the treament 
of selected cases of RD.
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